HIV Screening in Pregnancy

Journal of Obstetrics and Gynaecology Canada

Volumn 28, Issue 12, 2006, Pages 1103-1107

  Keenan Lindsay, Lisa ^a   Yudin, Mark H ^a   Boucher, Marc ^a   Ronald Cohen, Howard ^a   Gruslin, Andrée ^a   Jane MacKinnon, Catherine ^b   Money, Deborah M ^a   Paquet, Caroline ^a   Steben, Marc ^a   van Schalkwyk, Julie ^a   Wong, Thomas ^a  

^a NONE   (Canada)

^b Brantford ON   (Canada)

Author keywords

AIDS; Counselling; HIV; Perinatal; Pregnancy; Screening

Indexed keywords

ANTIRETROVIRUS AGENT;

ARTICLE; CANADA; FOLLOW UP; HIGH RISK BEHAVIOR; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMED CONSENT; MANDATORY TESTING; PATIENT ATTITUDE; PATIENT COUNSELING; PATIENT DECISION MAKING; PREGNANT WOMAN; PRENATAL CARE; PUERPERIUM; SCREENING; STIGMA; VERTICAL TRANSMISSION; DISEASE TRANSMISSION; FEMALE; MASS SCREENING; MEDICAL SOCIETY; OBSTETRICS; PRACTICE GUIDELINE; PREGNANCY; PREGNANCY COMPLICATION; STANDARD;

CANADA; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV INFECTIONS; HUMANS; MASS SCREENING; OBSTETRICS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SOCIETIES, MEDICAL;

EID: 36049014114     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)32327-1     Document Type: Article

References (35)

1. Public Health Agency of Canada. National HIV prevalence and incidence estimates for 2002. Centre for Infectious Disease Prevention and Control. Ottawa 2005.
2. Public Health Agency of Canada. HIV and AIDS in Canada: Surveillance report to December 31, 2004. HIV/AIDS Clearinghouse, Canadian Public Health Association. April 2005.
3. Peckham C., Gibb D. Mother to child transmission of the human immunodeficiency virus. N Engl J Med 1995, 333:298-302.
4. Mofenson L.M., McIntyre J.A. Advances and research directions in the prevention of mother-to-child HIV-1 transmission. Lancet 2000, 355:2237-2244.
5. Connor E.M., Sperling R.S., Gelber R., Kiseley P., Scott G., O'Sullivan M.J., et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994, 331:1173-1180.
6. Dorenbaum A., Cunningham C.K., Gelber R.D., Culnane M., Mofenson L., Britto P., et al. Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial. JAMA 2002, 288:189-198.
7. Ioannidis J.P.A., Abrams E.J., Ammann A., Bulterys M., Goedert J.J., Gray L., et al. Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads <1000 copies/mL. J Inf Dis 2001, 183:539-545.
8. Cooper E.R., Charurat M., Mofenson L., Hanson I.C., Pitt J., Diaz C., et al. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr 2002, 29:484-494.
9. Walmsley S. Opt in or opt out: What is optimal for prenatal screening for HIV infection?. CMAJ 2003, 168:707-708.
10. Canadian Paediatric Society Testing for human immunodeficiency virus type I (HIV-1) infection in pregnancy. Paediatr Child Health 2001, 6(9):685-689.
11. American Academy of Pediatrics and American College of Obstetricians and Gynecologists. Human immunodeficiency virus screening. Pediatrics 1999, 104:128.
12. Institute of Medicine, National Research Council. Reducing the odds: preventing perinatal transmission of HIV in the United States 1999, National Academy Press, Washington, DC.
13. Woolf L.A., Battista R.N., Angerson G.M., Logan A.G., Eel W. Canadian Task Force on the Periodic Health Examination 1994, xxxvii. Canada Communication Group, Ottawa.
14. Health Canada. Perinatal transmission of HIV. Available at: Accessed: October 7, 2003. http://www.hc-sc.gc.ca/pphb-dgspsp/publicat/epiu-aepi/hiv-vih/peri_e.html.
15. O'Connor K., MacDonald S., Hartling L., Seguin R., Hollands H., Mowat D.L., et al. The influence of prevalence and policy on the likelihood that a physician will offer HIV screening in pregnancy. Can J Public Health 2002, 93(1):31-35.
16. Duval M., Faye A., Rohrlich P., Levine M., Matheron S., Larchee R., et al. Failure of pediatric AIDS prevention despite maternal HIV screening in Paris, France. J Acquir Immune Def Syndr Hum Retrovirol 1999, 20:100-101.
17. Postma M.J., Beck E.J., Hankins C.A., Mandalia S., Jager J.C. de Jong-van den Berg, et al. Cost effectiveness of expanded antenatal HIV testing in London. AIDS 2000, 14(5):2383-2389.
18. Nakchbandi I.A., Longenecker J.C., Ricksecker M.A., Latta R.A., Healton C., Smith D.G. A decision analysis of mandatory compared with voluntary HIV testing in pregnant women. Ann Intern Med 1998, 128:760-767.
19. Peckham C.S., Newell M. Controversy in mandatory HIV screening of pregnant women. Curr Opin Infect Dis 1997, 10:18-21.
20. Bitnum A., King S.M., Arneson C., Read S.E. Failure to prevent perinatal HIV infection. CMAJ 2002, 166(7):904-905.
21. Postma M.J., Beck E.J., Mandalia S., Sherr L., Walters M.D.S., Houweling H., et al. Universal HIV screening of pregnant women in England: cost effectiveness analysis. BMJ 1999, 318:1656-1660.
22. Ades A.E., Gupta R., Gibb D.M., Duong T., Nicoll A., Goldberg D., et al. Selective versus universal antenatal HIV testing: epidemiological and implementational factors in policy choice. AIDS 1999, 13(2):271-278.
23. Patrick D.M., Money D.M., Forbes J., Dobson S., Rekart M., Cook D.A., et al. (1998). Routine prenatal screening for HIV in a low-prevalence setting. CMAJ 1998, 159(8):942-947.
24. Update. HIV testing among pregnant women- United States and Canada, 1998-2001. MMWR Morb Mortal Wkly Rep 2002, 51:1013-1016.
25. Kiarie J., Nduati R., Koigi K., Musia J., John G. HIV-1 testing in pregnancy: acceptability and correlates of return for test results. AIDS 2000, 14:1468-1470.
26. O'Connor K.S., MacDonald S.E. Aiming for zero: preventing mother-to-child transmission of HIV. CMAJ 2002, 166(7):909-910.
27. Rey D., Carrieri M., Obadia Y., Pradier C., Moatti J. Mandatory prenatal screening for the human immunodeficiency virus: the experience in south-eastern France of a national policy, 1992-1994. Br J Obstet Gynaecol 1998, 105:269-274.
28. Jayaraman G.C., Preiksaitis J.K., Larke B. Mandatory reporting of HIV infection and opt-out prenatal screening for HIV infection: effect on testing rates. CMAJ 2003, 168(6):679-682.
29. Stringer E.M., Stringer J.S.A., Cliver S.P., Goldenberg R.L., Goepfert A.R. Evaluation of a new testing policy for human immunodeficiency virus to improve screening rates. Obstet Gynecol 2001, 98:1104-1108.
30. Katz A. HIV Screening in Pregnancy: what women think. J Obstet Gynecol Neonatal Nurs 2000, 30(2):184-191.
31. Samson L., King S. Evidence-based guidelines for universal counselling and offering of HIV testing in pregnancy in Canada. CMAJ 1998, 158:1449-1457.
32. Oldenettel D., Dye T.D., Artal R. Prenatal HIV screening in pregnant women: a medical-legal review. Birth 1997, 24(3):165-172.
33. Wiktor S.Z., Ekpini E., Karon J.M., Nkengasong J., Maurice C., Severin S.T., et al. Short-course oral zidovuidine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Cote d'Ivoire: a randomized trial. Lancet 1999, 353:781-785.
34. Shaffer N., Chuachoowong R., Mock P.A., Bhadrakom C., Siriwasin W., Young N.L., et al. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomized controlled trial. Lancet 1999, 353:773-780.
35. Guay L.A., Musoke P., Fleming T., Bagenda D., Allen M., Nakabiito C., et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999, 354:795-802.